- Home
- SACH vs OSTX Comparison
SACH vs OSTX Comparison
Compare SACH & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SACH
- OSTX
- Stock Information
- Founded
- SACH 2010
- OSTX 2018
- Country
- SACH United States
- OSTX United States
- Employees
- SACH N/A
- OSTX N/A
- Industry
- SACH Real Estate Investment Trusts
- OSTX
- Sector
- SACH Real Estate
- OSTX
- Exchange
- SACH Nasdaq
- OSTX NYSE
- Market Cap
- SACH 79.4M
- OSTX 86.5M
- IPO Year
- SACH 2017
- OSTX 2024
- Fundamental
- Price
- SACH $1.60
- OSTX $1.95
- Analyst Decision
- SACH Buy
- OSTX Strong Buy
- Analyst Count
- SACH 2
- OSTX 1
- Target Price
- SACH $3.00
- OSTX $21.00
- AVG Volume (30 Days)
- SACH 562.1K
- OSTX 25.8K
- Earning Date
- SACH 11-14-2024
- OSTX 11-15-2024
- Dividend Yield
- SACH 15.05%
- OSTX N/A
- EPS Growth
- SACH N/A
- OSTX N/A
- EPS
- SACH N/A
- OSTX N/A
- Revenue
- SACH $10,951,064.00
- OSTX N/A
- Revenue This Year
- SACH N/A
- OSTX N/A
- Revenue Next Year
- SACH N/A
- OSTX $9,900.00
- P/E Ratio
- SACH N/A
- OSTX N/A
- Revenue Growth
- SACH N/A
- OSTX N/A
- 52 Week Low
- SACH $1.44
- OSTX $1.58
- 52 Week High
- SACH $4.64
- OSTX $4.90
- Technical
- Relative Strength Index (RSI)
- SACH 23.75
- OSTX N/A
- Support Level
- SACH $1.44
- OSTX N/A
- Resistance Level
- SACH $1.76
- OSTX N/A
- Average True Range (ATR)
- SACH 0.14
- OSTX 0.00
- MACD
- SACH -0.04
- OSTX 0.00
- Stochastic Oscillator
- SACH 17.51
- OSTX 0.00
About SACH Sachem Capital Corp.
Sachem Capital Corp is a United States-based real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.